Gelesis Holdings Inc At IPO Edge Fireside Chat Transcript
Good afternoon, thank you for joining. I'm John Jannarone, Editor-in-Chief of IPO Edge. We have a very special group of guests here with us today. We have 3 gentleman from the (inaudible) early this year, we have CEO, CFO along with the Chief Commercial and Chief Operating Officer. You are going to meet Yishai, Elliot and David in just a minute here. Gelesis is a biotech company developing a new category of therapies for GI-related chronic illnesses.
Plenity is product, is the first and only nature-inspired approach that helps you lose weight by mimicking the physical properties of vegetables. So very much nature inspired. We're going to get all into that, how it was developed, where the company is going. Before we do, I just want to remind everyone, if you'd like to watch a replay, if you don't catch the whole thing this afternoon, you can find that in our homepage later today, ipo-edge.com.
You can just as easily find it on your Bloomberg terminal or on Yahoo! Finance under the ticker GLS trades on the NYSE. And then if you want to ask questions, just shoot them to us there in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
